UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011850
Receipt number R000013850
Scientific Title Search of the pathogenicity factor in peripheral blood and its removing method in a rheumatic disease.
Date of disclosure of the study information 2013/12/01
Last modified on 2014/09/25 15:05:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Search of the pathogenicity factor in peripheral blood and its removing method in a rheumatic disease.

Acronym

Search of the pathogenicity factor in peripheral blood and its removing method in a rheumatic disease.

Scientific Title

Search of the pathogenicity factor in peripheral blood and its removing method in a rheumatic disease.

Scientific Title:Acronym

Search of the pathogenicity factor in peripheral blood and its removing method in a rheumatic disease.

Region

Japan


Condition

Condition

Rheumatic disease(ex Systemic Lupus Erythematosus, rheumatoid arthritis).

Classification by specialty

Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Apheresis is a safe and effective method even in an intractable rheumatic disease(ex Systemic Lupus Erythematosus, Rheumatoid arthritis).
The aims of this study are to analyze proteins distributions which trapped in an adsorption column and to inspect removal method for a pathogenic factor.
This study may find out an improved apheresis devices which fit more intractable disease.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Peripheral blood cytokine levels before and after apheresis procedures.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Over 20 years Rheuatic disease patients who treated with an usual apheresis therapy at Juntendo university hospital, Tokyo, Japan.

Key exclusion criteria

Patients who reject to entry this study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ken Yamaji

Organization

Juntendo Universitiy

Division name

Department of Internal Medicine and Rheumatology

Zip code


Address

3-1-3 Hongo, Bunkyo, Tokyo, Japan

TEL

03-3813-3111

Email

k.yamaji@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Makio Kusaoi

Organization

Juntendo Universitiy

Division name

Department of Internal Medicine and Rheumatology

Zip code


Address

3-1-3 Hongo, Bunkyo, Tokyo, Japan

TEL

03-3813-3111

Homepage URL


Email

k.yamaji@juntendo.ac.jp


Sponsor or person

Institute

Juntendo Universitiy,Department of Internal Medicine and Rheumatology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2013 Year 11 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

retrospective study


Management information

Registered date

2013 Year 09 Month 24 Day

Last modified on

2014 Year 09 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013850


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name